Semaglutide · complete guide
Microdose semaglutide: complete guide
Definitions, approved-product trials, evidence, risks, and cost for microdose semaglutide.
This is the complete guide to microdose semaglutide: what the term means, how it relates to approved semaglutide products and their trials, what the evidence supports, the risks, the cost drivers, and what remains unknown. Semaglutide is a single GLP-1 receptor agonist. Its weight-management evidence comes chiefly from the STEP program (e.g., STEP 1 and the STEP 4 maintenance-withdrawal design). Compounded semaglutide is not FDA approved.
What microdose semaglutide means
'Microdose semaglutide' has no single clinical definition. Providers apply it to a range of below-maintenance approaches, so the milligrams behind two 'semaglutide microdose' plans can differ widely. The honest starting point is to ask a provider exactly what dose, concentration, and form they mean.
Approved semaglutide products & trials
Semaglutide is the active ingredient in Wegovy and Ozempic (both injectable) and Rybelsus (an FDA-approved oral tablet). Rybelsus is the only approved oral semaglutide and is a specific manufactured product — it is not the same as a compounded 'oral semaglutide' drop or troche.
Because an approved oral semaglutide exists, the compounded-oral story here is especially prone to confusion: a compounded sublingual or ODT semaglutide is not Rybelsus and does not inherit its evidence.
- STEP 1: weight loss at 2.4 mg weekly vs placebo.
- STEP 4: continued 2.4 mg vs switch-to-placebo after a run-in — the maintenance/withdrawal signal.
What the evidence shows
- Semaglutide's dose-response is established for the approved product.
- STEP 4 shows maintenance on continued semaglutide and regain after placebo.
What the evidence does not show
- That a sub-therapeutic 'semaglutide microdose' reproduces trial weight loss.
- That compounded oral/sublingual semaglutide equals Rybelsus.
Risks
The main risks are dosing errors from units-vs-milligrams confusion when a compounded semaglutide concentration changes, unproven absorption for oral/sublingual forms, and the false assumption that 'less' is automatically safer or equally effective. Compounded semaglutide has drawn specific FDA attention over salt forms (semaglutide sodium/acetate), which are not the same active ingredient as the approved base — a reason to verify ingredient identity.
Cost
Compare microdose semaglutide programs on effective monthly cost, not headline prices — see the semaglutide cost page and the true-cost calculator.
Frequently asked questions
Is microdose semaglutide FDA approved?
No. There is no approved 'semaglutide microdose'; compounded low-dose semaglutide is not FDA approved.
Does microdose semaglutide work for weight loss?
Unproven. The weight-loss evidence is for approved semaglutide at studied doses, not a deliberate microdose.
Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.